NASDAQ · Biotechnology

CNTN (CNTN) Stock

$1.86 -2.11% NASDAQ: CNTN Healthcare

Valuation

MetricValue
Price$1.86
Market Cap$65.23M
P/E Ratio-3.14
P/B Ratio0.31
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$9.08
52-Week Low$1.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-9.05%
ROA-6.94%
ROCE-5.03%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio5.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-7.0M$-9.0M$-12.0M$-20.0M
Net Profit$-2.0M$-8.0M$-9.0M$-12.0M$-36.0M
EPS$-72.81$-280.77$-107.08$-9.41$-1.12
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$7.0M$11.0M$4.0M$519.0M
Total Liabilities$5.0M$1.0M$2.0M$2.0M$121.0M
Cash$0$7.0M$11.0M$4.0M$17.0M
Borrowings$2.0M$0$0$0$0

Latest News

Tharimmune Stockholders Elect Board, Ratify Auditor at 2026 Annual Meeting MarketBeat · Jul 14, 2026 Canton Strategic Holdings, Inc. Announces Launch of Locking Service to Support Network Infrastructure Providers PR Newswire · Jun 23, 2026 We're Not Very Worried About Canton Strategic Holdings' (NASDAQ:CNTN) Cash Burn Rate Simply Wall St. · May 15, 2026 Tharimmune Highlights Canton Network Q1 Growth, Tokenomics Shift and Validator Locking in Webinar MarketBeat · Apr 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-7.0M$-7.0M$-11.0M$-16.0M
Investing Cash Flow$0$0$0$0$-78.0M
Financing Cash Flow$0$-1.0M$-1.0M$-1.0M$107.0M
Net Cash Flow$0$7.0M$4.0M$-7.0M$13.0M
Free Cash Flow$-1.0M$-7.0M$-7.0M$-11.0M$-16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-17.07%
Quick Ratio37.75
Interest Coverage—
Return 1Y38.99%
Return 3Y-98.37%
Return 5Y—

Ownership

Insiders Held17.51%
Institutions Held16.99%
Institutions Float Held20.60%
Institutional HolderSharesReport Date
ARK Investment Management, LLC3,695,0842026-03-31
Valor Management LLC1,084,0112026-03-31
Blackrock Inc.765,8292026-03-31
Sumitomo Mitsui Trust Group, Inc.728,1672026-03-31
Amova Asset Management Americas Inc728,1672026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADAPAdaptimmune Therapeutics plc $0.05 -3.00% -0.16 $75.16M 0.00%
ADTX $0.01 -77.22% -0.01 $318 0.00%
AIMD $1.49 -3.87% -0.43 $10.97M 0.00%
ANLAdlai Nortye Ltd. $13.26 +2.00% -8.19 $703.84M 0.00%
APLMApollomics, Inc. $18.76 +2.99% -2.41 $20.69M 0.00%

About CNTN

CNTN is led by CEO Mark Wendland, employs 2 people, headquartered in US, publicly traded since 2024.

CNTN stock trades at $1.86 with a market capitalization of $65.23M. The stock is valued at a price-to-earnings (P/E) ratio of -3.14, price-to-book of 0.31, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.08 and $9.08, and currently trades 79.5% below its 52-week high.

On profitability, CNTN generates a return on equity (ROE) of -9.05%, return on capital employed of -5.03%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides